SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Speculating in Takeover Targets -- Ignore unavailable to you. Want to Upgrade?


To: richardred who wrote (983)3/2/2006 1:36:47 AM
From: richardred  Read Replies (1) | Respond to of 7256
 
AmerisourceBergen to buy Brecon
Wednesday March 1, 5:06 pm ET

NEW YORK (Reuters) - Drug wholesaler AmerisourceBergen Corp. (NYSE:ABC - News) said on Wednesday it acquired Brecon Pharmaceuticals Ltd., a privately held, United Kingdom-based provider of contract packaging and clinical trial materials services, for about $49 million in cash.

The acquisition also includes a contingent payment of up to $19 million, based on Brecon achieving specific earnings targets in calendar year 2006. The purchase is expected to be neutral to AmerisourceBergen's fiscal 2006 earnings.

biz.yahoo.com